share_log

Barclays Maintains Overweight on Elevance Health, Raises Price Target to $621

Moomoo 24/7 ·  Apr 19 08:36

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $584 to $621.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment